deoxypyridinoline has been researched along with Endometriosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuo, H | 1 |
| Borderie, D; Cherruau, B; Dougados, M; Ekindjian, OG; Roux, C | 1 |
| Amama, EA; Minaguchi, H; Taga, M | 1 |
| Kiesel, L; Parviz, M; Runnebaum, B; Seibel, MJ; Sillem, M; Ulrich, U; von Holst, T; Woitge, HW; Ziegler, R | 1 |
2 trial(s) available for deoxypyridinoline and Endometriosis
| Article | Year |
|---|---|
Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment.
Topics: Adult; Alkaline Phosphatase; Amenorrhea; Amino Acids; Biomarkers; Bone Density; Calcium; Cohort Studies; Collagen; Double-Blind Method; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyproline; Luteolytic Agents; Menstruation; Osteocalcin; Parathyroid Hormone; Time Factors; Triptorelin Pamoate | 1998 |
Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Bone and Bones; Bone Density; Bone Remodeling; Double-Blind Method; Endometriosis; Female; Goserelin; Humans; Kinetics; Medrogestone; Osteocalcin; Osteoporosis; Placebos; Premenopause; Progesterone Congeners | 1999 |
2 other study(ies) available for deoxypyridinoline and Endometriosis
| Article | Year |
|---|---|
Prediction of the change in bone mineral density induced by gonadotropin-releasing hormone agonist treatment for endometriosis.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Middle Aged; Peptide Fragments; Predictive Value of Tests; Procollagen; Prospective Studies | 2004 |
The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Remodeling; Buserelin; Collagen; Collagen Type I; Endometriosis; Estradiol; Female; Goserelin; Humans; Hydroxyproline; Leiomyoma; Osteocalcin; Peptides; Retrospective Studies | 1998 |